Healthtech & Wellness VC Funds

The Lightsmith Group is a private equity firm that specializes in investing in growth-stage companies focused on climate resilience and adaptation. Their inaugural fund, Lightsmith Climate Resilience Partners, closed with $186 million in commitments, making it the first private equity fund specifically aimed at climate resilience technologies. The firm targets sectors such as water efficiency, smart agriculture, geospatial intelligence, and catastrophe risk management. Founded by Jay Koh and Sanjay Wagle, Lightsmith Group applies its investment expertise to help scale companies that offer solutions to the growing physical impacts of climate change, including droughts, agricultural stress, and supply chain disruptions. Notable investments include SOURCE Global, a water harvesting company, and WayCool Foods, which optimizes the food supply chain in India. They focus on delivering both financial returns and measurable social and environmental impacts. The firm’s investment strategy is supported by leading global investors, including the Green Climate Fund, European Investment Bank, and The Rockefeller Foundation. By leveraging its global network, Lightsmith helps companies expand internationally, particularly in emerging markets​.

Lightrock is a global private equity firm that focuses on investing in sustainable businesses led by purpose-driven entrepreneurs. The firm aims to drive systemic change at scale through innovation, aligning its investments with impact themes such as "people," "planet," and "productivity/tech for good." Founded under the umbrella of LGT, Lightrock is committed to creating positive societal and environmental returns alongside financial gains​. Lightrock's diverse portfolio includes over 60 high-growth companies worldwide. Notable investments include Infarm, a rapidly growing urban farming network; PharmEasy, a leading omni-channel healthcare platform in India; and M-Kopa, a pioneer in pay-as-you-go solar energy services for off-grid customers in East Africa​. The firm actively supports its portfolio companies, often taking board positions to guide their dynamic growth and expansion. Headquartered in London, Lightrock operates globally with a team of more than 55 investment professionals across four continents, encompassing extensive experience in impact investing, leadership, and entrepreneurship. The firm is led by CEO Pal Erik Sjatil, the former Managing Partner of McKinsey & Company Europe​.

Lightship Capital is a venture capital firm with a distinct mission to empower and invest in underrepresented entrepreneurs. Based in Cincinnati, Ohio, Lightship specifically targets startups led by BIPOC (Black, Indigenous, and People of Color), women, LGBTQ+ individuals, and people with disabilities. Their investments span across the Midwest and South, purposefully avoiding oversaturated markets like Silicon Valley, New York, and Boston. The fund’s industry focus includes sectors such as Consumer Packaged Goods (CPG), E-commerce, Sustainability, Artificial Intelligence (AI), and Health Tech. Notable investments include companies like Healthy Roots Dolls, Vyrill, and ProovTest, which exemplify their commitment to supporting high-growth, impactful businesses. Lightship typically invests at the pre-seed to Series A stages, with an average check size of around $2 million. They are known for actively leading rounds and bringing in Executives-in-Residence with experience from major corporations like Procter & Gamble and Cincinnati Children’s Hospital to support portfolio companies. The firm is led by General Partners Candice Matthews Brackeen and Brian Brackeen, who bring extensive experience in fund management and technology. Their approach to sourcing deals emphasizes building relationships within underrepresented communities and fostering long-term success through hands-on mentorship and strategic guidance. For startups looking to connect with Lightship, aligning with their mission to drive systemic change in the venture capital landscape is crucial.

Lightspeed Venture Partners, founded in 2000, is a prominent global venture capital firm based in Menlo Park, California. The firm specializes in multi-stage investments, supporting companies from seed to growth stages. Lightspeed's investment focus spans several sectors, including enterprise, consumer, fintech, and healthcare. Some of Lightspeed's notable investments include Snapchat, Affirm, and Rubrik. Snapchat, a popular social media platform, went public in 2017, marking a significant success for the firm. Affirm, a financial technology company, also achieved a successful IPO in 2021. Rubrik, a leader in cloud data management, is another key company in their portfolio that highlights Lightspeed's focus on disruptive technology. Lightspeed Venture Partners has raised substantial funds over the years to support its diverse portfolio. In 2020, the firm raised $4.2 billion across three funds: an early-stage venture fund, a growth fund for later-stage investments, and an opportunity fund for doubling down on successful investments. The firm's philosophy centers on deep commitment and collaboration with founders, providing not just capital but also strategic guidance and support to help build enduring companies. With a global presence and a history of backing innovative companies, Lightspeed continues to be a key player in the venture capital landscape.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Link Ventures is a prominent Nordic venture capital firm with a strategic focus on accelerating the energy transition and building scalable technology solutions. Specializing in early-stage investments from pre-seed to Series A, Link Ventures prioritizes sectors such as clean energy, software, mobility, and tech that drive sustainable development. Notable investments by Link Ventures include SolarDuck, an innovative player in marine technology and renewable energy, and Glint Solar, specializing in AI-driven solar energy solutions. They actively invest in startups like Vignita, focusing on B2B corporate training, and Rightcharge, enhancing automotive charging solutions. Geographically, Link Ventures has a strong presence in Nordic and European markets, aiming to support over 100 early-stage companies across Europe. Their investment strategy involves not only financial backing but also active involvement in portfolio companies through strategic support, networking, and board representation. They typically invest between €100,000 to €5M, often leading investment rounds. The team at Link Ventures is led by seasoned professionals including Elisabeth Øvstebø, Founding Partner and Investment Director, and Christian Rangen, Chairman of the Board. They are based in Norway and are recognized for their hands-on approach and commitment to creating high-impact, sustainable businesses. Startups looking to engage with Link Ventures are encouraged to approach with a clear focus on innovation and sustainability, aligning with the firm's mission to foster the next generation of technology that addresses global energy challenges​.

LionBird, founded in 2012 and based in Tel Aviv and Chicago, focuses on early-stage investments in digital health companies. The firm targets startups that are leveraging technology to innovate and improve healthcare delivery and outcomes. Their diverse portfolio includes companies such as Ovia Health, a leader in family health solutions; Marqeta, a modern card issuing platform; and Bizzabo, an event management software company. LionBird has achieved notable exits including Ovia Health and Marqeta, which underline their strategic investment approach and successful track record. LionBird recently closed its third fund at $85 million, indicating strong support from institutional investors like the Healthcare of Ontario Pension Plan (HOOPP). This fund is set to invest in 15 to 20 early-stage companies within the digital health sector, reinforcing their commitment to transforming healthcare through technology. The firm is co-founded by Edward Michael JD, Chaim Friedman, and Jonathan Friedman, who bring extensive experience and a strong network to support their portfolio companies. LionBird aims to provide more than just capital, offering strategic guidance and resources to help startups navigate the complexities of the healthcare industry and achieve market fit.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Listen Ventures, based in Chicago, is a venture capital firm dedicated to investing in consumer-focused brands. Founded in 2010, Listen Ventures operates with a unique approach by combining capital with brand strategy, creativity, and consumer insights to help entrepreneurs build impactful brands. The firm has raised $92 million across two funds: Listen Ventures III, a $62 million core fund for early-stage investments, and Listen Up, a $30 million opportunity fund for later-stage investments in its existing portfolio. Notable investments include brands like Calm, Catch Co, Dame, Factor, and Interior Define​. Listen Ventures emphasizes a concentrated investment strategy, preferring to invest larger amounts of capital and resources into fewer companies. This allows them to provide comprehensive support, including strategic and creative guidance. Their investment thesis centers on identifying shifts in cultural narratives and consumer behavior, backing brands that address these shifts effectively.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LiveOak Venture Partners, based in Austin, Texas, is a prominent venture capital firm dedicated to investing in early-stage tech and tech-enabled service companies primarily within Texas. Founded in 2012 by Krishna Srinivasan and Venu Shamapant, LiveOak has successfully positioned itself as a leading VC firm focused on nurturing Texas-based startups. The firm has raised three major funds, with the latest being a $210 million Fund III, which surpassed its initial target of $150 million. This makes it the largest Texas-focused early-stage VC fund raised in the past decade. LiveOak's investment strategy is centered on leading or co-leading seed, Series A, and occasionally pre-seed and growth-stage investments, with initial checks ranging from $500K to $10M. They focus on sectors like healthcare technology, information technology, and tech-enabled services. LiveOak's portfolio includes notable companies such as DISCO, OJO Labs, Digital Pharmacist, and Opcity. These companies have either achieved successful exits or have continued to grow under LiveOak’s guidance. The firm prides itself on being deeply involved with its portfolio companies, providing strategic advice, leveraging a vast network, and assisting in crucial hires and growth strategies. LiveOak's commitment to Texas is evident not only in its investment focus but also in its community initiatives like LiveOak Gives, which supports local non-profit organizations. This hands-on, community-oriented approach has helped LiveOak foster a thriving entrepreneurial ecosystem in Texas, contributing significantly to the region's economic growth.

LocalGlobe, founded by Robin and Saul Klein in 1999, is a leading venture capital firm based in London. The firm focuses on seed and early-stage investments, typically investing $0-1 million. LocalGlobe has built a strong reputation for supporting startups from their inception to successful Series A rounds, often within 15 to 18 months. LocalGlobe is known for its hands-on approach, leveraging a network of industry experts and mentors to help portfolio companies navigate early-stage challenges. The firm looks for founders with a strong vision and passion for their industry, prioritizing solutions that address significant real-world problems. This strategy has led to investments in some of the most transformative companies, such as fintech giants, digital banking solutions, and innovative technology firms. Their focus is primarily on the UK market, deploying about 80% of their capital locally. This commitment to nurturing local talent has solidified their position as one of the most influential seed investors in Europe. LocalGlobe's approach and strategic investments have significantly impacted the global startup ecosystem, making them a crucial player in the venture capital landscape.

Lockstep Ventures is a $50 million venture capital firm dedicated to addressing systemic racial disparities across key areas such as health, wealth, education, and workforce development. Founded with a mission of driving economic justice and generating market-rate returns, Lockstep focuses on investing in founders of color and companies that create impactful solutions for underserved communities in the U.S. Lockstep's investment philosophy, “Disparity to Prosperity,” targets businesses that tackle racial inequality through innovative approaches, particularly in telehealth, financial inclusion, and workforce development. By focusing on sectors where racial disparities are most evident, the firm aims to create scalable solutions that close economic gaps while driving profitability. The firm is co-founded by Marcus Glover, a seasoned investor and advocate for criminal justice reform. Glover’s leadership and deep commitment to social justice have positioned Lockstep Ventures as a force for transformative change, with portfolio companies advancing in sectors like fintech and telehealth. The firm also supports initiatives like Fair Chance hiring, which aims to reduce barriers to employment for formerly incarcerated individuals.

Locus Ventures is a seed-stage venture capital firm founded by alumni from Google, Facebook, and Y Combinator. The firm focuses on investing in early-stage startups with the potential to create significant impact in various industries. Notable companies in their portfolio include Meesho, an online reselling platform; Ironclad, a contract lifecycle management software; and GitLab, a prominent DevOps platform that went public in 2021. Locus Ventures primarily invests in startups within the U.S. and Asia, leveraging their extensive experience and network in Silicon Valley and beyond. Their investment strategy emphasizes close collaboration with founders, providing guidance on product development and market strategy. They are known for their hands-on approach, often leading seed rounds and participating actively in the growth of their portfolio companies. The firm is led by partners Eric Kwan, William Chan, Perry Tam, and Tommy Tsai, who bring diverse backgrounds in technology and entrepreneurship. Locus Ventures has a track record of successful exits, including acquisitions by major companies such as Stripe and Nestlé.

Loeb.nyc is a New York-based venture collective founded by Michael Loeb and Rich Vogel. Rather than functioning as a traditional VC firm, Loeb.nyc offers a unique model that pairs capital investment with deep operational support, creating what they call a "venture collective." This model allows startups to access a wide range of expert resources including marketing, design, operational support, and strategic guidance. The goal is to empower entrepreneurs to focus on scaling their businesses, while Loeb.nyc handles many of the executional challenges that often burden early-stage companies. With a focus on direct-to-consumer, fintech, health, and tech solutions, Loeb.nyc’s portfolio is diverse and designed to foster collaboration between companies. Some notable portfolio companies include Fetch Rewards, a popular mobile app that helps shoppers save money, and InsightRX, which optimizes healthcare outcomes through precision medicine. By fostering a collaborative startup ecosystem, Loeb.nyc enables its companies to share resources and best practices, enhancing their chances of success. The leadership duo of Michael Loeb and Rich Vogel brings over three decades of entrepreneurial and investment experience, having previously built billion-dollar businesses like Synapse Group. Their hands-on approach and focus on community-building make Loeb.nyc a key player in the early-stage startup ecosystem.

Long Journey Ventures, founded in 2019 and based in San Francisco, focuses on early-stage investments across various sectors, including enterprise applications, consumer products, and emerging technologies. The firm has built an impressive portfolio featuring notable companies like Affirm, Uber, SpaceX, and Carta. They have also invested in innovative startups such as Flexport, Grove Collaborative, and Checkr. Long Journey Ventures typically invests in seed and Series A rounds, with an average round size of $17 million. Their strategy includes both leading and participating in funding rounds, providing strategic support and leveraging their extensive network to help startups scale. The firm has successfully nurtured nine unicorns, including Together AI, Crusoe, and Density. The leadership team includes experienced professionals like Cyan Banister, Lee Jacobs, and Arielle Zuckerberg, who bring deep expertise in venture investing and a strong track record of successful exits. Long Journey Ventures has been active with recent investments in sectors like satellite communication (Northwood Space) and cloud security (LimaCharlie), highlighting their commitment to supporting groundbreaking technologies and innovative business models.

Longbow Capital is a UK-based venture capital firm that has been investing in the healthcare, life sciences, and well-being sectors since its founding in 2004. Headquartered in Norwich, the firm primarily focuses on unquoted UK companies with strong growth potential. Longbow Capital specializes in identifying investment opportunities that can deliver exceptional returns for its high-net-worth and professional clients. With a proven track record in both early and late-stage investments, Longbow is particularly interested in innovative healthcare technologies and life sciences, as well as companies that align with the growing well-being industry. The firm's portfolio includes standout companies such as Calon Cardio-Technology and Destiny Pharma, which have progressed through clinical trials and even to IPOs, reflecting Longbow’s ability to back transformative ventures. Longbow is also actively involved in fostering partnerships with innovation hubs like the Boots Centre for Innovation, a collaboration aimed at bringing cutting-edge health and well-being products to market. This initiative, based in Swansea, provides a pathway for early-stage companies and inventors to scale their products within established retail networks, ensuring greater market access. A key aspect of Longbow’s investment strategy is its focus on tax-efficient investment vehicles such as the Enterprise Investment Scheme (EIS) and Business Property Relief (BPR). These schemes offer UK investors significant tax relief on their investments, including income tax, capital gains tax, and inheritance tax benefits. This tax-efficient approach, combined with the firm's deep sector expertise, positions Longbow as a leading investor in the UK’s dynamic healthcare and life sciences landscape​.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Longevity Vision Fund (LVF) is a venture capital firm based in New York City, founded by Sergey Young. The fund focuses on investing in technologies and companies that aim to extend healthy human lifespans and address the negative effects of aging. With a $100 million fund, LVF supports innovations in preventive medicine, early detection, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. LVF's mission is to accelerate breakthroughs in longevity and make these advancements more accessible and affordable to the general public. Notable investments include Senda Biosciences, a company dedicated to developing treatments through its proprietary molecular platform. The fund is led by Sergey Young, a prominent figure in the longevity space with over 20 years of investment experience. Other key team members include Avetik Arakelyan, Sourav Sinha, and Kris Verburgh, who bring diverse expertise in healthcare, technology, and finance. LVF targets early-stage investments and partners with innovative companies worldwide, aiming to transform the life sciences and healthcare industries. They emphasize a long-term commitment to improving human health and promoting a healthier, longer life for everyone.

Longitude Capital is a healthcare-focused venture capital firm that invests across biotechnology, medical technology, and health solutions sectors. Established in 2006, the firm seeks out transformative companies that can improve clinical outcomes, enhance quality of life, and drive healthcare efficiencies. They invest across various stages, from startups to growth companies, with a unique focus on areas like oncology, neurodegenerative diseases, aging, and cardiovascular solutions. Longitude's approach is flexible, allowing them to invest in early clinical-stage companies, spin-outs, and even publicly traded firms. The firm is known for its involvement in special situations, including recapitalizations and PIPEs (Private Investment in Public Equity). They have a proven track record with successful IPOs and acquisitions, such as Aimmune Therapeutics, KaNDy Therapeutics, and Axonics Modulation Technologies. With $585 million raised in its latest fund (LVP4), Longitude Capital's strategy remains rooted in long-term value creation, bolstered by robust internal research teams. Their offices are located in Menlo Park, Greenwich, and Boston, and they continue to partner with both emerging and established healthcare innovators.

Longwall Ventures is a UK-based venture capital firm specializing in early-stage investments in the health, resilience, and sustainability sectors. Founded with a mission to support innovative startups, Longwall Ventures has a strong focus on companies that leverage science and engineering to create impactful solutions. Notable investments by Longwall Ventures include Wayland Additive, which develops advanced 3D printing technologies; Lightcast Discovery, a biotechnology firm; and Caristo Diagnostics, which focuses on cardiovascular diagnostics. The firm has also invested in Closed Loop Medicine, a company developing personalized drug and digital therapy combinations, and LettUs Grow, which specializes in vertical farming technology. Longwall Ventures is known for its hands-on approach, providing not only capital but also strategic support to its portfolio companies. With a diverse portfolio of over 40 companies, Longwall Ventures continues to play a crucial role in fostering innovation and supporting the growth of early-stage companies in the UK and beyond.

Longwood Fund, founded in 2010 and based in Boston, Massachusetts, is a venture capital firm specializing in creating and investing in science-based companies that develop novel solutions to address important medical needs. The fund's principals have co-founded 25 companies, serving as CEOs, Chief Business Officers, and lead investors, and have helped advance over 20 products to market. Longwood Fund's portfolio includes several notable companies such as Grail, which focuses on early cancer detection, and TScan Therapeutics, which develops novel T cell therapies for cancer. Other significant investments include Immunitas Therapeutics, a company using single-cell genomics to innovate in immune oncology, and Be Biopharma, which is developing engineered B cells as a new category of cellular medicines. The fund emphasizes a value-add investment approach, actively supporting its portfolio companies in accelerating clinical progress from lab to patient. With a strong track record of successful exits, including Pyxis Oncology and PTC Therapeutics, Longwood Fund continues to play a pivotal role in advancing healthcare innovations.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.

Looking Glass Capital is an early-stage venture capital firm focused on mission-driven founders addressing major global challenges in health, climate, and empowerment. Founded by Adam Besvinick, the firm typically invests in pre-seed and seed rounds, often positioning itself as the “first yes” for startups. They prioritize companies developing disruptive technologies, especially those that enhance access, self-expression, and identity. Their investments range from $300k to $500k, usually participating in funding rounds between $750k and $3 million. Looking Glass is highly involved with the startups they back, providing not just capital, but ongoing support through strategic advice, networks, and guidance. The firm is known for being hands-on, valuing strong relationships with founders, and is almost always available for consultations, aiming to be a significant early-stage partner. Their portfolio includes a variety of impactful companies, such as Daily Blends and WattCarbon, reflecting their focus on sustainable, forward-thinking sectors​.

Lool Ventures is a Tel Aviv-based early-stage venture capital firm that invests primarily in Israeli startups. Founded in 2012, the firm focuses on seed and pre-seed funding, helping ambitious entrepreneurs build innovative companies that can compete on a global scale. Lool Ventures is sector-agnostic, with investments spanning across areas such as fintech, digital health, SaaS, AI, logistics, and more, demonstrating a commitment to backing technology that transforms industries. The firm is known for its hands-on approach, partnering closely with startups to provide not just capital but also strategic guidance, mentorship, and operational support. Lool Ventures typically leads or co-leads investment rounds, and its involvement often extends from the earliest stages through Series A. The firm’s diverse portfolio includes companies like Bringg, a leading logistics platform; CyberMDX, which focuses on healthcare cybersecurity; and Zencity, a data analytics platform for local governments. Lool Ventures’ team, led by General Partners Avichay Nissenbaum and Yaniv Golan, brings a wealth of entrepreneurial experience, which helps them connect with founders and anticipate the challenges faced during the growth phase. With assets under management totaling around $200 million, Lool Ventures continues to play a significant role in Israel’s startup ecosystem, seeking out visionary founders who are ready to innovate and disrupt traditional markets.

Lorimer Ventures is a venture capital firm that specializes in investing in early-stage B2B SaaS companies. Their key focus areas include fintech, e-commerce tooling, developer tools, intelligent infrastructure, and future of work applications. They pride themselves on being highly supportive and responsive, often engaging deeply with their portfolio companies to provide strategic guidance, introductions to customers, investors, and talent, and valuable insights from their extensive network of experienced operators and executives. The team at Lorimer Ventures includes notable figures like Stephan Cizmar, a serial entrepreneur with a background in scaling B2B software companies, and Nick Wijnberg, an investor with extensive experience in finance and agribusiness. They are complemented by operating partners like Pete Schork and Zach Magdovitz, who bring expertise in sustainable energy, mobility, and product management​. Lorimer Ventures has built a diverse portfolio of innovative companies, including TakeShape, Northbeam, Polar Signals, and Capchase, among others. Their approach is to roll up their sleeves and work closely with founders to drive their businesses forward.

Loup Ventures is a Minneapolis and New York-based venture capital firm focused on frontier technologies, including artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and robotics. Founded in 2017 by Andrew Murphy, Doug Clinton, and Gene Munster, the firm invests primarily in early-stage companies that are at the intersection of these emerging technologies. Loup Ventures is research-driven, leveraging in-depth analysis and insights to guide its investment decisions. Notable investments include Neurable, an AI company advancing brain-computer interfaces, and Skupos, a platform providing data solutions for convenience stores. The firm is known for its focus on high-impact sectors like neurotechnology, and the future of transportation, with its portfolio companies aiming to shape the way humans interact with machines and the digital world. Geographically, Loup Ventures focuses on investments across the U.S., with its team frequently engaging in thought leadership through articles and podcasts on technological trends. Their investment strategy emphasizes deep involvement, supporting founders not only financially but also with insights derived from their rigorous market research. The team, led by Gene Munster, a well-known tech analyst, and Andrew Murphy, brings extensive experience in tech and finance. Loup Ventures prefers a hands-on approach, often leading rounds and staying actively involved in guiding startups to scale. Startups looking to attract their attention should highlight disruptive tech in AI or AR, showcasing robust market research and a clear vision for the future.

Low Carbon Innovation Fund (LCIF), established in 2010 and based in Norwich, United Kingdom, focuses on investments in the clean technology sector. Managed by Turquoise International, LCIF supports small and medium-sized enterprises (SMEs) in developing products and services that have a beneficial environmental impact. The fund is primarily backed by the European Regional Development Fund and targets areas including renewable energy, energy efficiency, and sustainable materials​. Notable investments include companies like Skoot, an environmental services firm; Cellexcell, specializing in advanced materials; and Advanced Electric Machines, which focuses on sustainable electrical equipment. LCIF has also made significant exits, such as the sale of companies like Syrinix, which provides smart pipeline monitoring solutions, and Breathing Buildings, a specialist in natural ventilation systems​​. LCIF is known for its collaborative investment approach, often partnering with other investors to maximize impact. Recent co-investments include contributions to Net Zero Now, a platform that helps businesses achieve and certify their net zero carbon emissions​​. This strategy aligns with their broader mission to drive innovation and support the transition to a low-carbon economy.

Lowercarbon Capital, founded in 2018 by Chris and Crystal Sacca, is a venture capital firm dedicated to combating climate change through investments in innovative technologies. Based in Jackson, Wyoming, the firm focuses on backing companies that reduce CO2 emissions, remove existing carbon from the atmosphere, and develop solutions to mitigate the impacts of climate change. Notable investments include Lilac Solutions, which is revolutionizing lithium extraction; Solugen, which produces chemicals using enzymes instead of oil; Commonwealth Fusion Systems, working on fusion energy; and Mosa Meat, creating lab-grown meat to reduce livestock emissions. Lowercarbon Capital has invested in over 160 companies, aiming to combine hard science with ambitious goals to tackle climate challenges. The firm’s strategy emphasizes both financial returns and environmental impact, supporting startups from the R&D stage to seed funding with checks ranging from $50,000 to $1 million. Their comprehensive approach includes not only capital but also strategic guidance and support for founders through a robust ecosystem of industry experts and fellow entrepreneurs​. Led by a team of experienced investors and scientists, including managing partner Chris Sacca, Lowercarbon Capital is positioned at the forefront of climate tech innovation, making significant strides in various sectors such as energy, agriculture, and industrial materials.

Lowercase Capital, founded by Chris Sacca in 2010, is a renowned venture capital firm based in San Francisco. The firm specializes in early-stage investments and has built a notable portfolio featuring some of the most successful tech startups of the past decade. Their investments include iconic companies such as Twitter, Uber, Instagram, Twilio, Stripe, and Kickstarter. These high-profile successes have helped establish Lowercase Capital as a significant player in the venture capital landscape. Lowercase Capital has made around 250 investments, spanning various industries including technology, media, and consumer products. They are particularly known for their involvement in Y Combinator companies, investing in startups like 9gag, Stripe, and Docker. The firm's strategy involves not only providing capital but also offering extensive support and guidance to their portfolio companies, leveraging Chris Sacca's extensive experience and network within the tech industry. The firm's notable exits include Slack, Instagram, and Twitter, which have contributed significantly to Lowercase Capital's reputation and financial success. These exits highlight the firm's ability to identify and nurture companies with substantial growth potential. Lowercase Capital is also known for its philanthropic efforts, supporting startups that empower and help people in need, such as charity: water and the Anti-Recidivism Coalition. Chris Sacca, the founder, has been recognized for his impactful contributions to both the business and philanthropic sectors, making him a prominent figure in the venture capital community.

Loyal VC is a global venture fund established in 2018 that operates a startup index fund with over 350 investments across more than 60 countries. The firm is known for its unique gate-stage investment process, which reduces systemic bias and aims to unlock greater returns. This process involves multiple rounds of diligence and quarterly redemptions, offering flexibility to high-net-worth individuals and institutions. Loyal VC collaborates closely with INSEAD, Founder Institute, and a network of over 1,000 advisors. This extensive network supports a diverse portfolio of founders, with more than 30% of the portfolio companies led by women CEOs and nearly 30% based in emerging markets. The firm places a strong emphasis on social impact, with 80% of its investments aligned with one or more of the UN Sustainable Development Goals (SDGs). Notable investments by Loyal VC include Sama, a company that brings transparency and verifiability to cross-border blue-collar recruitment, and TechStyle, a digital marketplace for sustainable material sourcing in the fashion industry. The firm also supports companies like CurieMD, a telemedicine platform for menopause care, and Milestone, a financial literacy app aimed at helping parents raise financially responsible children. Loyal VC’s investment focus spans various sectors, including cleantech, fintech, healthcare, and more, reflecting their commitment to backing innovative solutions across the globe. For more information, you can visit their official website.

Ludlow Ventures, founded in 2009 and based in Detroit, Michigan, is a venture capital firm that takes a unique approach to investing by emphasizing strong personal relationships with entrepreneurs. The firm focuses on early-stage investments, particularly in the technology sector. Ludlow Ventures has built a robust portfolio, with notable companies such as Honey, a browser extension for online shopping deals acquired by PayPal; Wag, a dog-walking service; and Product Hunt, a platform for discovering new products. The firm has made over 160 investments and has achieved 24 exits, showcasing their ability to identify and support high-potential startups. Other significant investments include Headout, an on-demand mobile platform for booking tours and activities, and CoverTree, an insurtech company focused on property insurance. Ludlow Ventures operates with a philosophy of "VC without ego," striving to be collaborative and supportive partners to their portfolio companies. The team, led by Managing Partner Jonathon Triest, prides itself on being deeply involved in the success of the startups they back, providing not just capital but also strategic advice and resources.

Luge Capital is a venture capital firm based in Montreal, focused on fintech and AI solutions for financial services. Founded in 2018 by David Nault and Karim Gillani, Luge Capital specializes in early-stage investments, typically at the Seed and Series A stages, providing crucial support to startups reshaping how financial services are delivered. Their investments emphasize innovation in areas like payments, digital banking, and insurtech. The fund has raised over $71 million in its second close and aims to reach $100 million to continue backing fintech companies in both Canada and the U.S. Notable investments include companies like Flinks, which was acquired by National Bank, Plooto, and Owl.co. Luge seeks founders with bold ideas and a global vision, particularly those challenging traditional finance models with scalable technology. Luge Capital prides itself on being a hands-on partner, leveraging its strong network of financial institutions like Desjardins and CDPQ to provide portfolio companies with strategic guidance, customer access, and industry insights. The firm’s team has over 50 years of collective experience as founders, operators, and investors, making them a trusted resource for startups navigating the complexities of financial technology. For entrepreneurs, Luge is a valuable partner, offering not just capital, but also the deep operational expertise and networks needed to scale. Founders looking to work with Luge should have a clear, ambitious plan for disrupting the financial landscape.

Lumen Ventures is a Rome-based early-stage venture capital firm that focuses on investing in technology-driven startups, particularly at the seed stage. Established as the first Simple Investment Company (SiS) in Italy, Lumen Ventures manages a €25 million fund aimed at backing high-potential tech startups across sectors like fintech, insurtech, healthtech, and foodtech. Lumen Ventures differentiates itself by being led by a team of former entrepreneurs and operators, which gives them a practical understanding of the challenges faced by startups. This experience enables them to provide not only financial support but also strategic guidance to help founders scale their businesses both in Italy and across Europe. The firm typically invests between €100,000 and €1.5 million per company and is particularly keen on supporting second-time founders. By leveraging their industry expertise and entrepreneurial background, the Lumen Ventures team is committed to helping startups build sustainable growth pathways.

Lumira Ventures is a prominent venture capital firm specializing in life sciences and healthcare investments. Established in 1989 and headquartered in Toronto, Canada, Lumira Ventures has a robust presence across North America, with offices in Toronto, Montreal, Vancouver, and Boston. The firm focuses on backing innovative biotechnology and medical technology companies that have the potential to address significant unmet medical needs and improve healthcare quality globally. The firm's investment portfolio includes a wide range of companies such as Depomed, Guava Technologies, Think Research, and U-Systems, showcasing their diverse interest in biopharmaceuticals and medical devices. Notable recent investments include Antiva Biosciences, developing topical therapies for HPV-related pre-cancerous lesions, and Arclight Therapeutics, focusing on neurodegenerative diseases. Lumira Ventures' investment strategy involves providing substantial support to their portfolio companies, from early-stage funding to strategic guidance. They recently closed their Lumira Ventures IV fund at $220 million, the largest life sciences venture fund ever raised in Canada, highlighting their significant role in the sector. Overall, Lumira Ventures is dedicated to advancing healthcare innovation through strategic investments and active support of pioneering companies in the life sciences domain.

LUMO Labs is a dynamic venture capital firm based in Eindhoven, Netherlands, that prioritizes impact-driven investments in emerging digital technologies. Focused on pre-seed to Series A stages, LUMO Labs targets startups in fields like AI, blockchain, robotics, IoT, and AR/VR. The firm is deeply committed to supporting innovations that address global challenges related to sustainable cities, health, well-being, and education. Its portfolio includes companies such as Alphabeats, Enliven, and Roboat, all of which push the boundaries of technology while contributing to societal progress. Founded by Andy Lürling and Sven Bakkes, LUMO Labs has gained recognition for its hands-on approach. Startups in their portfolio benefit from a two-year venture builder program, which provides personalized coaching, access to expert networks, and support tailored to each company's unique needs. This program focuses on four key pillars: leadership, product-market fit, storytelling, and follow-on investment, ensuring that startups scale effectively both economically and socially. With the recent launch of the €100 million LUMO Rise Fund, LUMO Labs has expanded its scope across Europe, investing in climate action, digital security, and projects aligned with the UN’s Sustainable Development Goals. LUMO Labs is driven by the belief that technological advancements can serve as powerful tools for creating a better and more sustainable future.

Lunar Ventures is a Berlin-based venture capital firm focused on investing in deep-tech startups across Europe. The firm specializes in early-stage companies, often leading seed rounds with investments ranging from €300K to €1M. Lunar Ventures primarily targets highly technical founders working on breakthrough innovations in fields like artificial intelligence, cryptography, cloud infrastructure, and advanced computing. Their mission is to support visionary entrepreneurs building cutting-edge technologies that address complex, global challenges. What sets Lunar Ventures apart is their deep technical expertise. The team comprises engineers, computer scientists, and tech-bio specialists who provide hands-on support to portfolio companies. This background enables them to understand and back startups tackling the most complex technical problems, often before they generate revenue. The firm is committed to helping these companies scale, offering both financial capital and strategic guidance throughout their development journey. Lunar’s portfolio reflects its commitment to innovation, featuring companies such as Zama, which focuses on privacy-preserving AI, and Bedrock, which is revolutionizing ocean floor mapping with autonomous underwater vehicles. Lunar’s approach to investing emphasizes a long-term vision, partnering with startups from seed to Series A and beyond, helping them navigate the challenges of growth in the deep-tech ecosystem. Based in Berlin, Lunar Ventures operates across Europe, working with companies that are redefining industries through science and engineering, and making an impact in sectors ranging from AI to biotech and beyond.

Lux Capital is a leading venture capital firm renowned for its investments in groundbreaking science and technology ventures. With a portfolio boasting companies like Recursion Pharmaceuticals, Desktop Metal, and Matterport, Lux Capital focuses on industries such as biotechnology, material science, and artificial intelligence. The firm invests primarily in early-stage startups but is versatile enough to support companies through later stages as well. Lux Capital is geographically centered in the United States, with a strong presence in New York and Silicon Valley. Their investment strategy is defined by backing counter-conventional ideas that push the boundaries of current technology and science. They are known for making substantial investments, often leading funding rounds, and providing robust support to their portfolio companies to ensure their long-term success. The firm is managed by an experienced team including co-founders Peter Hébert, Robert Paull, and Joshua Wolfe. Their approach is hands-on, offering not just capital but also strategic guidance, networking opportunities, and operational support. Lux Capital values innovative pitches and prefers to be approached with well-researched and transformative ideas. In recent years, Lux Capital has been highly active, raising significant funds like the $1.15 billion for its eighth fund. The firm’s commitment to pioneering technologies is evident in their diverse investments, from AI-driven biotech firms like Evolutionary Scale to innovative aerospace companies like Planet.

LvlUp Ventures is a dynamic, next-generation venture capital firm based in the United States, focusing on early to growth-stage investments. The firm operates with a robust ecosystem that blends traditional venture funding with hands-on support through accelerators, incubators, and strategic partnerships. Since its inception, LvlUp has built a portfolio of over 40 companies, collectively valued at over $750 million. The firm prides itself on championing diversity, with more than 40% of its portfolio companies founded by women or persons of color. LvlUp Ventures emphasizes a unique "up-the-funnel" investment approach, starting with early acceleration and providing follow-on capital through SPVs (Special Purpose Vehicles) for promising startups, increasing their chances of successful scaling. The firm is known for its NextUp program, which nurtures startups from seed to Series A, offering resources ranging from mentorship to go-to-market strategies, all tailored to each company's needs. Additionally, they collaborate with corporate giants like Google and Fidelity to create bespoke programs that help founders scale rapidly. Key members of the team, including General Partner Brandon Maier, bring decades of experience in scaling businesses, and they leverage a global network of venture scouts to source high-potential deals. The firm has built a thriving online community that connects founders, mentors, and investors, fostering growth and collaboration across its portfolio. With a data-driven approach and a deep commitment to founder success, LvlUp Ventures continues to establish itself as a leader in supporting the next wave of innovative startups.

Lytical Ventures is a New York-based venture capital firm focused on Enterprise Intelligence, with deep expertise in cybersecurity, artificial intelligence, and data analytics. Their portfolio features cutting-edge companies like Baffle, which provides advanced data security solutions, and RiskOptics, a leader in quantifying cybersecurity risk. They also back firms like Reality AI, which enhances signal recognition for connected devices. Their investment strategy targets early-stage startups that offer scalable, enterprise-ready solutions, often aligning with industries that manage critical infrastructure or complex data environments. Lytical Ventures prefers companies that are breaking barriers in tech innovation, with a keen eye on cybersecurity and AI-driven analytics. Geographically, the firm is U.S.-centric, but their investments serve global markets, reflecting the wide reach of enterprise intelligence applications. They are known for taking an active role in their investments, frequently providing mentorship and strategic guidance to their portfolio companies. Lytical Ventures typically leads or co-leads investment rounds and is highly selective, investing in companies that align with their expertise. Led by key partners like Jeff Keswin and Lucas Nelson, the firm’s team brings decades of venture experience, providing not just capital but also strategic partnerships and operational support to help startups scale. They prefer to build relationships over time, making them approachable for entrepreneurs with a well-defined value proposition in cybersecurity or enterprise AI.

M Capital Partners is a prominent French private equity and venture capital firm with €500 million in assets under management. The firm primarily focuses on the French small-cap market, investing in over 160 SMEs across a variety of sectors, including fashion, fintech, media, real estate, and more. Since 2015, M Capital has expanded into venture investing, with a focus on Seed to Series B rounds. It also manages a dedicated venture fund in partnership with the European Investment Fund and the Occitanie region. M Capital is known for its hands-on approach, partnering with entrepreneurs to foster long-term growth and transformation. The firm's portfolio companies collectively employ over 11,000 people and generate more than €2 billion in annual revenue. M Capital has offices in Paris, Toulouse, Bordeaux, Nice, and Lyon, and its investment team includes 40 professionals alongside 19 senior advisors. Their typical investment horizon is 3 to 5 years, and they offer flexible investment tickets ranging from €1 million to €5 million. They emphasize growth in industries driving innovation, and their investments often lead to strategic exits through IPOs or sales to larger corporations.

M Ventures, the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, was established in 2009. The fund focuses on investments in biotechnology, healthcare, life science tools, electronics, and frontier technologies aimed at sustainability. With a dual focus on strategic and financial returns, M Ventures has a broad investment portfolio that targets transformational ideas and innovative solutions. M Ventures has committed €600 million to support its investments, allowing it to back both early-stage and more advanced companies. The fund has a strong track record with over 115 deals and 86 portfolio startups. Notable investments include companies like Artios Pharma, which focuses on DNA damage response therapies for cancer, and Storm Therapeutics, which specializes in RNA modulation. The venture capital arm takes an active role in its portfolio companies, collaborating closely with entrepreneurs and co-investors to drive innovation and commercial success. M Ventures' strategy includes making early-stage investments and helping companies develop technologies that align with Merck’s long-term R&D goals.

M12, Microsoft's venture fund, focuses on early-stage investments, primarily in Series A and B rounds. Established in 2016, M12 has quickly become a significant player in the venture capital landscape, leveraging Microsoft's extensive network and resources to support its portfolio companies. M12's investment areas include AI, cloud infrastructure, cybersecurity, developer tools, vertical SaaS, and emerging technologies like Web3 and gaming. Notable investments by M12 include companies such as SpaceX, Addepar, GoPuff, BitGo, and Dataminr. Additionally, M12 has backed promising startups like BlueVine in vertical SaaS, Bolster in cybersecurity, and Bonsai in AI. M12 also focuses on fostering innovative solutions in autonomous systems and frontier technologies​. The fund operates with a close alignment to Microsoft, which allows it to provide unique benefits and opportunities for its portfolio companies, such as integrations with Microsoft Azure and other enterprise solutions. This strategic alignment helps startups accelerate their growth and expand their market reach by leveraging Microsoft's extensive ecosystem.

M13 is a venture capital firm based in Santa Monica, California, known for its early-stage investments in disruptive technology and consumer-focused companies. Founded in 2016 by brothers Carter and Courtney Reum, M13 has established a robust portfolio that includes notable companies such as Ring, Cue, Daily Harvest, FabFitFun, ClassPass, Matterport, and Capsule. M13's investment strategy spans several sectors including health, commerce, work, and money, with a strong focus on infrastructure technologies such as AI and web3. The firm leverages its Propulsion Platform, which combines operational expertise and strategic guidance to help startups scale efficiently. This platform ensures that each founder receives tailored support, significantly enhancing their chances of success. M13 has recently launched its third fund, raising $400 million to continue backing early-stage teams. Their approach involves writing checks of up to $15 million from Seed to Series B stages, often leading the investment rounds. This fund aims to capitalize on the evolving consumer behavior and the growing importance of horizontal technology layers, including blockchain-based applications governed through tokens.

M25 is an early-stage venture capital firm based in Chicago, focusing on investments in startups headquartered in the Midwest. Founded in 2015, M25 has quickly become one of the most active seed investors in the region, with over 90 investments across a variety of industries, including AI, fintech, e-commerce, healthcare, and software. Notable investments from M25 include companies like Upsie, a warranty services provider; Avail, a platform for landlords and tenants; and PactSafe, a contract acceptance platform. The firm has a strong focus on supporting innovative and high-growth potential startups, leveraging their extensive network and resources to help these companies scale effectively. M25’s investment strategy involves making initial investments ranging from $500,000 to $1.5 million and often taking board seats to provide strategic guidance. The firm emphasizes a data-driven approach to investment decisions and maintains a hands-on relationship with its portfolio companies to support their growth and success.

MaC Venture Capital, co-founded by Adrian Fenty, Marlon Nichols, Michael Palank, and Charles D. King, is a prominent seed-stage venture capital firm headquartered in Los Angeles and Silicon Valley. The fund focuses on investing in technology startups that leverage cultural shifts and trends. Notable investments include Gimlet Media, Truebill, Pipe, Edge Delta, Stoke, Zigazoo, and Spartan Radar, reflecting their strategic emphasis on technology, fintech, media, and mobile sectors. MaC VC is distinguished by its commitment to diversity; 36% of their portfolio companies are led by women, and 69% by BIPOC founders. Their investment strategy centers on backing early-stage companies with innovative solutions addressing large market needs. They typically lead rounds and write initial checks of significant amounts, maintaining substantial reserves to support follow-on investments in high-performing portfolio companies. The firm’s team, which includes key figures like Adrian Fenty and Marlon Nichols, brings a wealth of expertise across technology, politics, entertainment, and finance. This diverse leadership enhances their ability to provide comprehensive support in operations, brand building, and strategic introductions, crucial for scaling startups.\

Maccabee Ventures, established in 2019 and based in New York City, is an early-stage venture capital firm focused on investing in tech startups. Founded by Yeshiva University alumni, the firm leverages the university's extensive global alumni network to support its portfolio companies with industry expertise and strategic connections. The firm targets investments in various sectors, including SilverTech™, digital health, enterprise/B2B, fintech, cybersecurity, and converging technologies like AI and machine learning. Maccabee Ventures typically invests in pre-seed and seed-stage companies, with initial investments ranging from $50,000 to $150,000, and can provide follow-on funding up to $300,000. Notable investments in Maccabee Ventures' portfolio include companies such as Fundbox, a fintech platform for business loans; Hootsuite, a social media management platform; and Eleos Health, which leverages AI for digital health solutions. The firm also has investments in innovative companies like Clocr (digital inheritance and asset protection), Shabodi (5G technology), and Tembo Health (telemedicine)​. Maccabee Ventures prides itself on building meaningful relationships with founders and providing strategic support to help companies grow and scale. This includes leveraging Yeshiva University's resources and a network of over 70,000 alumni for expertise in various fields.

Macquarie Capital is the advisory, capital markets, and principal investment arm of the Macquarie Group, a global financial institution with a 30-year track record of investing in technology-driven businesses. Specializing in early-stage and growth-stage investments, Macquarie Capital focuses on sectors like cybersecurity, fintech, AI, regulatory technology, and food services, helping startups scale globally. The firm’s flexible investment model allows them to lead funding rounds and provide strategic support throughout a company’s lifecycle. With a portfolio that spans companies across Australia, Europe, Israel, and the UK, Macquarie Capital has established itself as a long-term partner for entrepreneurs driving innovation. Their hands-on approach provides founders access to an extensive network of experts, entrepreneurs, and industry partners, enabling rapid growth. Some of their current portfolio companies include BioCatch (AI-driven biometrics), D-ID (AI avatars), and Shield (digital communications governance). Macquarie Capital also integrates environmental, social, and governance (ESG) considerations into its investments, aiming to make a positive real-world impact. Beyond venture capital, Macquarie is active in areas like infrastructure, energy, and real estate, leveraging its global expertise to fuel sustainable growth in its investments.